We are live on ! Find out more
LBA

Letko, Brosseau & Associates Portfolio holdings

AUM $6.77B
1-Year Est. Return 38.11%
This Fund
S&P 500
This Quarter Est. Return
-13.62%
1 Year Est. Return
+38.11%
3 Year Est. Return
+83.35%
5 Year Est. Return
+109.01%
10 Year Est. Return
+317.99%
AUM
$5.65B
AUM Growth
-$1.05B
Cap. Flow
-$60.9M
Cap. Flow %
-1.08%
Top 10 Hldgs %
34.59%
Holding
104
New
3
Increased
29
Reduced
51
Closed
4

Top Sells

Rank Stock Value
1
SU icon
Suncor Energy
SU
+$40.5M
2
TECK icon
Teck Resources
TECK
+$33.1M
3
GSK icon
GSK
GSK
+$29.2M
4
OVV icon
Ovintiv
OVV
+$25M
5
CVE.WS
Cenovus Energy Inc Warrants
CVE.WS
+$24.1M

Sector Composition

Rank Sector Weight
1 Financials 29.01%
2 Communication Services 17.69%
3 Energy 13.64%
4 Materials 10.84%
5 Technology 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BABA icon
101
Alibaba
BABA
$272B
-3,100
Closed -$337K
GSK icon
102
GSK
GSK
$100B
-535,478
Closed -$29.2M
GT icon
103
Goodyear
GT
$1.53B
-387,108
Closed -$5.53M
PBA icon
104
Pembina Pipeline
PBA
$27.7B
-5,425
Closed -$204K

Similar funds

Letko, Brosseau & Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Letko, Brosseau & Associates held 104 positions worth $5.65B, down 16% from $6.7B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Letko, Brosseau & Associates's Q2 2022 filing shows 3 new, 29 increased, 51 reduced and 4 closed positions. Its largest new stake was Netflix: 860,000 shares worth $15M. The largest sale was Suncor Energy, an estimated $40.5M.

By sector, the portfolio is most concentrated in Financials at 29% of assets, down from 29% a quarter earlier, followed by Communication Services and Energy.

  • Letko, Brosseau & Associates's largest Q2 2022 buy was Netflix: 860,000 shares worth $15M.
  • Letko, Brosseau & Associates added most to Manulife Financial in Q2 2022, an estimated $26.9M increase.
  • Letko, Brosseau & Associates's biggest Q2 2022 reduction was Suncor Energy, cutting an estimated $40.5M.
  • Letko, Brosseau & Associates fully exited GSK in Q2 2022, selling an estimated $29.2M.
  • Letko, Brosseau & Associates's ten largest holdings make up 35% of its $5.65B portfolio in Q2 2022.
  • Letko, Brosseau & Associates opened 3 new positions and closed 4 in Q2 2022.
  • Letko, Brosseau & Associates's portfolio value fell 16% quarter-over-quarter to $5.65B.

Based on Letko, Brosseau & Associates's 13F filing for Q2 2022, filed 9 Aug 2022.